ColonCancerCheck Mailed Invitations: An Evaluation

Sponsor
Sunnybrook Health Sciences Centre (Other)
Overall Status
Completed
CT.gov ID
NCT02364895
Collaborator
Cancer Care Ontario (Other)
75,317
2
13

Study Details

Study Description

Brief Summary

This study evaluates effectiveness of mailed invitations for colorectal cancer screening among screen-eligible Ontarians who are due for screening. The study will evaluate the effectiveness of mailed invitations in general (compared to no invitation) but will also determine if new invitation letters (2 letters for male, 1 letter for females) are more effective than current invitation letters used by the ColonCancerCheck program.

Condition or Disease Intervention/Treatment Phase
  • Other: Males control group: Deferred letter
  • Other: Males Group 1: Current CCC invitation letter
  • Other: Males Group 2: New letter with neutral gender content
  • Other: Males Group 3: New letter with male-specific content
  • Other: Females control group: Deferred letter
  • Other: Females Group 1: Current CCC invitation letter
  • Other: Females Group 2: New letter with neutral gender content
N/A

Detailed Description

On April 1 2008, Ontario launched Canada's first organized province-wide CRC screening program, ColonCancerCheck (CCC). CCC has a dual strategy: through the primary care physician, FOBT is offered to people aged 50 to 74 years at average risk for colorectal cancer and colonoscopy to those at increased risk based on family history. In 2010-2011, approximately 30% of Ontarians 50-74 years old were screened for colorectal cancer using the FOBT. An important factor in increasing screening participation is an invitation system.

A central tenet of organized screening programs is that all persons in the target population be invited to participate. In 2010, CCC began implementing a correspondence program in an effort to improve participation in colorectal cancer screening, starting with recall letters to individuals who were due for repeat screening two years after a normal fecal occult blood test (FOBT) and invitation letters to screen-eligible individuals who are due for screening and have not received correspondence from CCO to participate in colorectal cancer screening in the past two years to complete a screening test for colorectal cancer. Individuals who are "due for screening" includes those who have not had a FOBT in the past 2 years, a flexible sigmoidoscopy in the past 5 years, and a colonoscopy in the past 10 years. Currently, CCC sends 10,000 invitation letters monthly to 50-54 year olds only. In October 2013, the CCC correspondence program expanded to also include all eligible Ontarians 55-74 years old.

The current CCC invitation letter includes general information on the benefits of screening for colorectal cancer, the screening test itself (FOBT), and contact information to get more information. It is meant to invite individuals to speak with their primary care provider about colorectal screening. In 2013 Diego Llovet, a lead qualitative researcher at CCO, completed a series of qualitative studies examining the content of current CCC correspondence materials and made recommendations to improve the content of invitation letters. These recommendations were based on four key types of information: a) findings from seven focus groups with screen-eligible Ontarians (men and women, 50-74) who provided feedback on the messages that should be included in these letters, b) input provided by six experts in health communications and health promotion on the content and style of effective cancer screening correspondence, c) evidence from behavioral science studies on barriers to participation in colorectal cancer screening, and d) theories of health behavior change. Based on findings from focus group studies examining the content of the current CCC letter, a unisex and a male-tailored invitation letter were developed. A female-tailored letter was not developed as the focus group studies with females showed that they did not prefer female tailored messaging to a unisex one.

In the current study, we propose to test the effectiveness of mailed invitations for colorectal cancer screening in the real world setting of the CCC program. We will evaluate the effectiveness of mailed invitations in general (i.e., compared to no invitation) but we will also determine whether letters developed based on theories from behavioural science and on the results of qualitative studies with Ontarians in the target population are more effective than those currently used by the program. The findings from this study will be used to inform the CCC program correspondence but will also provide valuable information for the development of correspondence for other screening programs at Cancer Care Ontario and in other jurisdictions engaged in organized screening programs.

Study Design

Study Type:
Interventional
Actual Enrollment :
75317 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Investigator)
Primary Purpose:
Screening
Official Title:
ColonCancerCheck Mailed Invitations: An Evaluation
Study Start Date :
Nov 1, 2013
Actual Primary Completion Date :
May 1, 2014
Actual Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Male arm

Males control group: Deferred letter Males Group 1: Current CCC invitation letter Males Group 2: New letter with neutral gender content Males Group 3: New letter with male-specific content

Other: Males control group: Deferred letter
This letter will be sent 6 months after index (mailing) date

Other: Males Group 1: Current CCC invitation letter
This letter is currently used by the program in 50-54 year olds

Other: Males Group 2: New letter with neutral gender content
Unisex letter

Other: Males Group 3: New letter with male-specific content
New letter tailored for men

Experimental: Female arm

Females control group: Deferred letter Females Group 1: Current CCC invitation letter Females Group 2: New letter with neutral gender content

Other: Females control group: Deferred letter
This letter will be sent 6 months after index (mailing) date

Other: Females Group 1: Current CCC invitation letter
This letter is currently used by the program in 50-54 year olds

Other: Females Group 2: New letter with neutral gender content
Unisex letter

Outcome Measures

Primary Outcome Measures

  1. fecal occult blood test (FOBT) uptake [6 months after the mailing date]

    Using the administrative databases at CCO, participating individuals will be followed up 6 months after the index date to measure FOBT uptake.

Secondary Outcome Measures

  1. FOBT or colonoscopy uptake [6 months]

    Using the administrative databases at CCO, participating individuals will be followed up 6 months after the index date to measure FOBT of colonoscopy uptake.

  2. Intermediate outcomes [8-12 weeks after mailing date]

    We will mail a simple questionnaire 8-12 weeks after the index date to participants in order to assess intermediate outcomes including (a) recall of letter, (b) knowledge of colorectal cancer screening, (c) intent to be screened for colorectal cancer.

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years to 74 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 55-74 year old Ontarians with an active OHIP number
Exclusion Criteria:
  • Death

  • Withdrawn from program correspondence

  • Prior colorectal cancer diagnosis

  • Any FOBT activity within the last two years, including

  • Flexible sigmoidoscopy within the last five years.

  • Colonoscopy within the last ten years

  • Other medical history in the last 30 months

  • Exclusion from screening in the last 30 months

  • Received a birthday letter, invitation or recall within the last two years

  • Inactive primary address

  • Missing address

  • Address outside Ontario

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Sunnybrook Health Sciences Centre
  • Cancer Care Ontario

Investigators

  • Principal Investigator: Jill Tinmouth, MD PhD FRCPC, Sunnybrook Health Sciences Centre, Cancer Care Ontario

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sunnybrook Health Sciences Centre
ClinicalTrials.gov Identifier:
NCT02364895
Other Study ID Numbers:
  • 375-2013
First Posted:
Feb 18, 2015
Last Update Posted:
Feb 18, 2015
Last Verified:
Feb 1, 2015
Keywords provided by Sunnybrook Health Sciences Centre

Study Results

No Results Posted as of Feb 18, 2015